Back to LLY
ASR Vermogensbeheer N.V. → LLY
ASR Vermogensbeheer N.V. LLY Position History
Eli Lilly and Company • Healthcare
Quarters held
5
Latest value
$170.5M
Q3 2026
Peak value
$170.5M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $114.9M |
| Q4 2025 | $149.8M |
| Q1 2026 | $127.6M |
| Q2 2026 | $170.5M |
| Q3 2026 | $170.5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $170.5M | 147.3K | — | — |
| Q2 2026 | $170.5M | 142.2K | — | — |
| Q1 2026 | $127.6M | 138.7K | — | — |
| Q4 2025 | $149.8M | 139.4K | — | — |
| Q3 2025 | $114.9M | 150.7K | — | — |
Other funds holding LLY
$108.4B
$104.2B
$99.1B
$84.5B
$79.5B
$72.9B
$62.3B
$59.7B